Select Disease
|
Select Disease |
| Home | • | About | • | Our Team | • | Expert Opinion | • | CuraBase Workspace | • | Contact |
|
| Disease | Trials | Epidemiology | Molecular Aberrations | PDQ |
|---|---|---|---|---|
| Acute Lymphocytic Leukemia | See Trials | See Data | Go to NIH PDQ® | |
| Acute Lymphocytic Leukemia (Ph+) | See Trials | |||
| Acute Myeloid Leukemia | See Trials | See Data | Go to NIH PDQ® | |
| Adrenocortical Cancer | See Trials | Go to NIH PDQ® | ||
| Advanced Cancer | See Trials | |||
| Advanced Hematologic Malignancies | See Trials | |||
| Advanced Solid Tumors | See Trials | |||
| Aerodigesive Cancers | See Trials | |||
| Anal Cancer | See Trials | See Data | Go to NIH PDQ® | |
| Anaplastic large cell lymphoma (ALCL) | ||||
| Angiosarcoma | See Trials | |||
| Basal Cell Carcinoma | See Trials | Go to NIH PDQ® | ||
| Biliary Cancer | See Trials | See Data | Go to NIH PDQ® | |
| Bladder Cancer | See Trials | See Data | 9 mutations | Go to NIH PDQ® |
| Breast Cancer | See Trials | See Data | 30 mutations | Go to NIH PDQ® |
| Bronchoalveolar Cancer | See Trials | 1 mutations | ||
| Carcinoid | See Trials | |||
| Carcinoma | See Trials | |||
| Cervical Cancer | See Trials | See Data | 5 mutations | |
| Cholangiocarcinoma | See Trials | 1 mutations | ||
| Chondrosarcoma | See Trials | |||
| Chronic Myelogenous Leukemia (Accelerated Phase) | See Trials | |||
| Chronic Myelogenous Leukemia (Chronic Phase) | See Trials | |||
| Chronic Myelogenous Leukemia (MBC) | See Trials | |||
| Chronic Myelogenous Leukemia (LBC) | See Trials | |||
| Colorectal Cancer | See Trials | See Data | 26 mutations | Go to NIH PDQ® |
| Endometrial Cancer | See Trials | See Data | 7 mutations | Go to NIH PDQ® |
| Esophageal Cancer | See Trials | See Data | 31 mutations | Go to NIH PDQ® |
| Ewing's sarcoma | See Trials | Go to NIH PDQ® | ||
| Fallopian Tube Cancer | See Trials | |||
| Fibroblasts | ||||
| Gallbladder Cancer | See Trials | 4 mutations | Go to NIH PDQ® | |
| Gastric Cancer | See Trials | See Data | 23 mutations | Go to NIH PDQ® |
| Gastric Lymphoma (MALT) | ||||
| Gastro-intestinal Stromal Tumor (GIST) | See Trials | |||
| Gastroesophageal Cancer | See Trials | |||
| Gastrointestinal Cancer | See Trials | See Data | ||
| Giant Cell Cancer | See Trials | |||
| Glioblastoma | See Trials | 25 mutations | Go to NIH PDQ® | |
| Gliomas | See Trials | 4 mutations | ||
| Head and Neck Cancer | See Trials | See Data | 5 mutations | Go to NIH PDQ® |
| Hepatobiliary Cancer | See Trials | |||
| Hepatocellular Carcinoma | See Trials | 1 mutations | Go to NIH PDQ® | |
| Hodgkin's Disease | See Trials | See Data | Go to NIH PDQ® | |
| Hurthle sarcoma | See Trials | |||
| In vitro Enzyme Activity | ||||
| Kidney Cancer | See Trials | See Data | Go to NIH PDQ® | |
| Laryngeal Cancer | See Data | Go to NIH PDQ® | ||
| Leukemia | See Trials | |||
| Lip and Oral Cavity Cancer | Go to NIH PDQ® | |||
| Liposarcoma | See Trials | Go to NIH PDQ® | ||
| Liver Cancer | See Trials | Go to NIH PDQ® | ||
| Lung Cancer | See Trials | See Data | Go to NIH PDQ® | |
| Lung Cancer (non-small cell) | See Trials | 32 mutations | Go to NIH PDQ® | |
| Lung Cancer (small cell) | See Trials | 4 mutations | Go to NIH PDQ® | |
| Lymphoid Malignancies | See Trials | |||
| Lymphoid/Myeloid malignancies | ||||
| Lymphoma | See Trials | |||
| Lymphoma - Non-Hodgkin | See Trials | See Data | Go to NIH PDQ® | |
| Lymphoma, B-cell | Go to NIH PDQ® | |||
| Lymphoma, T-cell | See Trials | Go to NIH PDQ® | ||
| Melanoma | See Trials | See Data | 8 mutations | Go to NIH PDQ® |
| Mesothelioma | See Trials | Go to NIH PDQ® | ||
| Multiple Myeloma | See Trials | See Data | Go to NIH PDQ® | |
| Myelodysplastic syndrome | See Trials | Go to NIH PDQ® | ||
| Myelofibrosis | See Trials | |||
| Myeloid Malignancies | ||||
| Nasopharyngeal Cancer | See Trials | Go to NIH PDQ® | ||
| Neuro-endocrine tumors | See Trials | |||
| Normal Human T-cells | ||||
| Normal Human Vascular Endothelial Cells | ||||
| Oral Dysplasia | See Trials | |||
| Oropharyngeal Cancer | See Data | Go to NIH PDQ® | ||
| Osteosarcoma | See Trials | See Data | Go to NIH PDQ® | |
| Other | See Trials | |||
| Ovarian Cancer | See Trials | See Data | 56 mutations | Go to NIH PDQ® |
| Pancreatic Cancer | See Trials | See Data | 34 mutations | Go to NIH PDQ® |
| Parotic Gland Cancer | See Trials | |||
| Peritoneal Cancer | See Trials | |||
| Pharynx Cancer | See Trials | 1 mutations | ||
| Polycythemia Vera | See Trials | |||
| Prostate Cancer | See Trials | See Data | 12 mutations | Go to NIH PDQ® |
| Pseudomyxoma Peritonei | See Trials | |||
| Rectal Cancer | See Trials | See Data | Go to NIH PDQ® | |
| Renal Cell Cancer | See Trials | See Data | Go to NIH PDQ® | |
| Salivary gland cancer | See Trials | |||
| Sarcoma | See Trials | Go to NIH PDQ® | ||
| Skin Cancer (Squamous) | See Trials | Go to NIH PDQ® | ||
| Soft Tissue Sarcoma | See Trials | See Data | Go to NIH PDQ® | |
| Solid Tumors | See Trials | |||
| Stomach Cancer | See Trials | |||
| Target Enzyme Activity | ||||
| Testicular Cancer | See Trials | See Data | Go to NIH PDQ® | |
| Thymoma | See Trials | Go to NIH PDQ® | ||
| Thyroid Cancer | See Trials | 15 mutations | Go to NIH PDQ® | |
| Tumor Cell Lines | See Trials | |||
| Unknown Primary | See Trials | |||
| Urothelial Cancer | See Trials | Go to NIH PDQ® | ||
| Uterine Cancer | See Trials | See Data | 1 mutations | Go to NIH PDQ® |